Breast Imaging

Siemens Healthineers announced that the U.S. Food and Drug Administration (FDA) has approved High Definition Breast Tomosynthesis. This unique form of digital breast tomosynthesis (DBT) includes new algorithms designed to deliver a heightened level of sensitivity to breast cancer detection and...

March 31, 2017 — A recent analysis of newly added 2014 data to the National Cancer Institute SEER database by R. Edward Hendrick, Ph.D., shows that the breast cancer death rate has now fallen 38 percent since 1990.

February 9, 2017 — Breast cancer patients with dense fibroglandular breast tissue have almost a two-fold increased risk of developing disease in the contralateral breast, according to new research from The University...

Fujifilm Medical Systems U.S.A. Inc. announced that its Digital Breast Tomosynthesis (DBT) software upgrade for its Aspire Cristalle digital mammography system, has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA). The optional DBT upgrade is now available in...

January 17, 2017 — James Laskaris, emerging technology analyst at MD Buyline, recently offered his perspective on five medical technology innovations that might be just months or a few years away.